Paul Gougis

35 papers receiving 470 citations

Hit Papers

Clinical spectrum and evolution of immune-checkpoint inhi...2024202620252024204060

Peers

Paul Gougis
Comparison fields: 5 of 88
  • Oncology 225
  • Molecular Biology 96
  • Pulmonary and Respiratory Medicine 81
  • Cardiology and Cardiovascular Medicine 59
  • Immunology 52
Replace Mark J. Ratain with:
Mark J. Ratain United States
Hüseyin Engin Türkiye
Chan Kk Malaysia
Patrick J. Medina United States
Satyajit Pradhan India
E. Boven Netherlands
Maura A. Kraynak United States
Subhash Chander India
J. Alexandre France
Sandra Cuéllar United States
Paul Gougis relative to Mark J. Ratain United States Mark J. Ratain's profile →
Citations per field
00.5×20×40×58×
Mark J. Ratain · 1×
Citations per year

Countries citing papers authored by Paul Gougis

Since Specialization
Citations

This map shows the geographic impact of Paul Gougis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gougis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gougis more than expected).

Fields of papers citing papers by Paul Gougis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gougis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gougis. The network helps show where Paul Gougis may publish in the future.

Co-authorship network of co-authors of Paul Gougis

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Gougis. A scholar is included among the top collaborators of Paul Gougis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Gougis. Paul Gougis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 0
4 0
5
Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspectivebreakdown →
67
6 1
7 2
8 4
9 0
10 1
11 21
12 2
13 4
14 14
15 1
16 2
17 3
18 14
19 15
20 18

About Paul Gougis

Paul Gougis is a scholar working on Oncology, Otorhinolaryngology and Hematology, having authored 44 papers that have together received 483 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Risks and Factors (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Oncology (225 citations), Toxicology (15 citations) and Otorhinolaryngology (15 citations). Paul Gougis has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Joe‐Elie Salem, Christian Funck‐Brentano, Javid J. Moslehi, Bénédicte Lebrun‐Vignes, Arthur Géraud, Yves Allenbach, Fabien Reyal, Élise Dumas, Olivier Mir and Baptiste Abbar. Their work appears in journals such as Journal of Clinical Oncology, European Heart Journal and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026